Literature DB >> 23274765

Superior working memory and behavioural habituation but diminished psychomotor coordination in mice lacking the ecto-5'-nucleotidase (CD73) gene.

Armin Zlomuzica1, Sandra Burghoff, Jürgen Schrader, Ekrem Dere.   

Abstract

Adenosine is an important neuromodulator in the central nervous system involved in the regulation of wakefulness, sleep, learning and memory, fear and anxiety as well as motor functions. Extracellular adenosine is synthesized by the cell-surface ectoenzyme ecto-5'-nucleotidase (CD73) from 5'-adenosine monophosphate. While CD73 is widely expressed throughout the mammalian brain, its specific role for behaviour is poorly understood. We examined spatial working memory, emotional responses, motor coordination and motor learning as well as behavioural habituation in mice with a targeted deletion of CD73. CD73 knockout (CD73-/-) mice exhibit enhanced spatial working memory in the Y-maze and enhanced long-term behavioural habituation in the open field. Furthermore, impaired psychomotor coordination on the accelerating rotarod was found in CD73-/- mice. No changes in motor learning and/or anxiety-like behaviour were evident in CD73-/- mice. Our data provide evidence for a role of CD73 in the regulation of learning and memory and psychomotor coordination. Our results might be important for the evaluation of adenosine neuromodulators as possible treatments to ameliorate cognitive and motor deficits associated with neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23274765      PMCID: PMC3646114          DOI: 10.1007/s11302-012-9344-1

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  45 in total

1.  Effects of A1 and A2 adenosine receptor antagonists on the induction and reversal of long-term potentiation in guinea pig hippocampal slices of CA1 neurons.

Authors:  S Fujii; H Kato; K Ito; S Itoh; Y Yamazaki; H Sasaki; Y Kuroda
Journal:  Cell Mol Neurobiol       Date:  2000-06       Impact factor: 5.046

2.  Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning.

Authors:  Catherine J Wei; Philipp Singer; Joana Coelho; Detlev Boison; Joram Feldon; Benjamin K Yee; Jiang-Fan Chen
Journal:  Learn Mem       Date:  2011-06-21       Impact factor: 2.460

Review 3.  Purinergic signalling: from normal behaviour to pathological brain function.

Authors:  Geoffrey Burnstock; Ute Krügel; Maria P Abbracchio; Peter Illes
Journal:  Prog Neurobiol       Date:  2011-09-01       Impact factor: 11.685

4.  Distinct contribution of the striatum and cerebellum to motor learning.

Authors:  R Laforce; J Doyon
Journal:  Brain Cogn       Date:  2001-03       Impact factor: 2.310

5.  Effects of inhibitory avoidance training and/or isolated foot-shock on ectonucleotidase activities in synaptosomes of the anterior and posterior cingulate cortex and the medial precentral area of adult rats.

Authors:  Grace Schenatto Pereira; Tadeu Mello e Souza; Ana Maria Oliveira Battastini; Iván Izquierdo; João José Freitas Sarkis; Carla Denise Bonan
Journal:  Behav Brain Res       Date:  2002-01-22       Impact factor: 3.332

6.  Preferential enhancement of working memory in mice lacking adenosine A(2A) receptors.

Authors:  Sai-Jun Zhou; Mei-Er Zhu; Dan Shu; Xun-Ping Du; Xiu-Hua Song; Xiao-Tong Wang; Rong-Yuan Zheng; Xiao-Hong Cai; Jiang-Fan Chen; Jin-Cai He
Journal:  Brain Res       Date:  2009-09-26       Impact factor: 3.252

7.  Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.

Authors:  F Suzuki; J Shimada; S Shiozaki; S Ichikawa; A Ishii; J Nakamura; H Nonaka; H Kobayashi; E Fuse
Journal:  J Med Chem       Date:  1993-08-20       Impact factor: 7.446

8.  Deletion of ecto-5'-nucleotidase (CD73) reveals direct action potential-dependent adenosine release.

Authors:  Boris P Klyuch; Nicholas Dale; Mark J Wall
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

Review 9.  The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects.

Authors:  Beáta Sperlágh; E Sylvester Vizi
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

10.  Physiological roles for ecto-5'-nucleotidase (CD73).

Authors:  Sean P Colgan; Holger K Eltzschig; Tobias Eckle; Linda F Thompson
Journal:  Purinergic Signal       Date:  2006-06-01       Impact factor: 3.765

View more
  6 in total

Review 1.  Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).

Authors:  Marquet Minor; Karel P Alcedo; Rachel A Battaglia; Natasha T Snider
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

Review 2.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

Review 3.  Sleep-Wake Regulation and Its Impact on Working Memory Performance: The Role of Adenosine.

Authors:  Carolin Franziska Reichert; Micheline Maire; Christina Schmidt; Christian Cajochen
Journal:  Biology (Basel)       Date:  2016-02-05

Review 4.  Ectonucleoside triphosphate diphosphohydrolases and ecto-5'-nucleotidase in purinergic signaling: how the field developed and where we are now.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2020-12-17       Impact factor: 3.765

5.  CD73 is a major regulator of adenosinergic signalling in mouse brain.

Authors:  Natalia Kulesskaya; Vootele Võikar; Marjaana Peltola; Gennady G Yegutkin; Marko Salmi; Sirpa Jalkanen; Heikki Rauvala
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

6.  Deletion of CD73 increases exercise power in mice.

Authors:  Aderbal S Aguiar; Ana Elisa Speck; Paula M Canas; Rodrigo A Cunha
Journal:  Purinergic Signal       Date:  2021-07-03       Impact factor: 3.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.